Literature DB >> 8423630

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients.

M Nguyen1, H Watanabe, A E Budson, J P Richie, J Folkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8423630     DOI： 10.1093/jnci/85.3.241

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  34 in total

Review 1.  A role for antiangiogenic therapy in breast cancer.

Authors:  Marsha A Moses; Jay Harper; Cecilia A Fernández
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

Review 2.  Targeting angiogenesis in bladder cancer.

Authors:  Aymen A Elfiky; Jonathan E Rosenberg
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

Review 3.  Recent advances in the study of tumour invasion and metastasis.

Authors:  D Tarin; Y Matsumura
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

Review 4.  Intratumor microvessel density as a prognostic factor in cancer.

Authors:  N Weidner
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

Review 5.  The preclinical evaluation of angiogenesis inhibitors.

Authors:  M S O'Reilly
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 6.  Growth factors in bladder cancer.

Authors:  M Liebert
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 7.  Incorporating VEGF-targeted therapy in advanced urothelial cancer.

Authors:  Sujata Narayanan; Sandy Srinivas
Journal:  Ther Adv Med Oncol       Date:  2016-09-16       Impact factor: 8.168

Review 8.  Molecular substratification of bladder cancer: moving towards individualized patient management.

Authors:  Anirban P Mitra
Journal:  Ther Adv Urol       Date:  2016-03-28

9.  The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.

Authors:  Norio Nonomura; Yasutomo Nakai; Masashi Nakayama; Hitoshi Inoue; Kazuo Nishimura; Eijirou Hatanaka; Ryouichi Arima; Tomomi Kishimoto; Tsuneharu Miki; Hideya Kuroda; Akihiko Okuyama
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

Review 10.  Cytokine therapeutics: lessons from interferon alpha.

Authors:  J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.